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Mitochondrial reactive oxygen species (ROS) play
a central role in most aging-related diseases. ROS
are produced at the respiratory chain that demands
NADH for electron transport and are eliminated
by enzymes that require NADPH. The nicotinamide
nucleotide transhydrogenase (Nnt) is considered a
key antioxidative enzyme based on its ability to
regenerate NADPH from NADH. Here, we show that
pathological metabolic demand reverses the direc-
tion of the Nnt, consuming NADPH to support NADH
and ATP production, but at the cost of NADPH-linked
antioxidative capacity. In heart, reverse-mode Nnt is
the dominant source for ROS during pressure over-
load. Due to a mutation of the Nnt gene, the inbred
mouse strain C57BL/6J is protected from oxidative
stress, heart failure, and death, making its use in car-
diovascular research problematic. Targeting Nnt-
mediated ROS with the tetrapeptide SS-31 rescued
mortality in pressure overload-induced heart failure
and could therefore have therapeutic potential in
patients with this syndrome.
INTRODUCTION
Whilemitochondria are themajor source of cellular ATP, they can
also emerge as important generators of reactive oxygen species
(ROS) (Balaban et al., 2005; Murphy, 2009). Increasedmitochon-
drial ROS production plays an important role in aging (Schriner
et al., 2005) and many aging-related diseases, including neuro-
degenerative (Lin and Beal, 2006), metabolic (Lee et al., 2010),472 Cell Metabolism 22, 472–484, September 1, 2015 ª2015 Elsevieand cardiac diseases (Dai et al., 2009). Chronic heart failure
is the most frequent cause of hospitalization in persons
agedR65 years and commonly results from myocardial infarc-
tion and/or hypertension (Roger, 2013), and in both scenarios,
mitochondrial ROS contribute to deterioration of cardiac func-
tion (Dai et al., 2012; Matsushima et al., 2006). In heart, ROS
impair excitation-contraction coupling, cause arrhythmias (Wag-
ner et al., 2013), activate prohypertrophic signaling (Ago et al.,
2008), and induce apoptotic and/or necrotic cell death through
activation of the permeability transition pore (PTP) (Halestrap,
2005). Recent advances in pharmacology targeting mitochon-
drial ROS production provide novel therapeutic options in a
broad spectrum of diseases (Smith et al., 2012; Szeto, 2014)
and require a precise understanding of the regulation of mito-
chondrial ROS production in physiology and disease.
The heart is an organ with uniquely high demands of ATP.
During exercise, ATP production can increase4-fold, requiring
efficient adaptation of respiration through ADP and Ca2+ (Bala-
ban, 2002; Cortassa et al., 2006). A physiological increase
in workload is triggered by b-adrenergic stimulation, which in-
creases ADP (through ATP hydrolysis) and at the same time,
cytosolic Ca2+ (Figure 1A). While ADP accelerates respiration
and oxidizes NADH to NAD+ by stimulating ATP production at
the F1Fo-ATP synthase, Ca
2+ enters mitochondria and activates
Krebs cycle dehydrogenases to regenerate NADH. This ‘‘parallel
activation’’ of respiration maintains constant ratios of ATP/ADP
and NADH/NAD+ over a wide range of physiological workloads
(Balaban, 2002).
We discovered recently that mitochondrial Ca2+ uptake is also
important to maintain NADPH for the elimination of hydrogen
peroxide (H2O2), since all enzymes that regeneratemitochondrial
NADPH derive their substrates from the Krebs cycle (Kohlhaas
et al., 2010) (Figure 1A). In heart failure, disturbed Ca2+ and
Na+ handling hamper mitochondrial Ca2+ uptake and thus,






Figure 1. Nnt Contributes to Antioxidative
Capacity during b-Adrenergic Stimulation
(A) Mitochondrial NADPH regeneration is accom-
plished by NADP+-dependent isocitrate-dehy-
drogenase 2 (IDH2), malic enzyme (MEP), and the
Nnt. GR, glutathione reductase; TR, thioredoxin
reductase; MCU, mitochondrial Ca2+ uniporter.
(B) Isolated myocytes from BL/6N and BL/6J mice
were electrically stimulated at 0.5 Hz and then
exposed to isoproterenol (30 nM) and stimulation
frequency increased to 5 Hz. Stimulation protocol
and representative trace of cell length.
(C–F) Systolic sarcomere shortening (C), mito-
chondrial membrane potential (DJm; by TMRM)
(D), mitochondrial dO2
 (by MitoSOX) (E), and
cellular ROS (by CM-H2DCFDA) (F) during the
protocol.
Data are presented asmeans ± SEM. *p < 0.05 BL/
6N versus BL/6J. See also Figure S1.emission (Kohlhaas et al., 2010). These and other studies led
to the concept of ‘‘redox-optimized ROS balance’’ (Aon et al.,
2010), which implies that both production of superoxide (dO2
)
at the electron transport chain (ETC; fueled by NADH) and elim-
ination of H2O2 (by NADPH-dependent enzymes) are favored by
reduced redox states (Figure 1A). In this scenario, mitochondria
are optimized to maximize energy output while keeping H2O2
overflow to a minimum by operating in an intermediate redox
state, while extreme oxidation or reduction can induce oxidative
stress (Aon et al., 2010).
The nicotinamide nucleotide transhydrogenase (Nnt) is at the
critical interface between the NADH and NADPH pools in mito-
chondria, and despite a high abundance in the heart, its precise
role for the regulation of mitochondrial ROS production and elim-
ination is not well understood. The Nnt catalyzes the reaction
NADH+NADP+4 NADPH+NAD+ and is coupled to the proton-
motive force (DmH; Figure 1A). Since high DmH in energized mito-
chondria favors NADPH production, the Nnt is deemed to be a
key antioxidative enzyme (Rydstro¨m, 2006). Recently, it was
discovered that C57BL/6 mice from The Jackson Laboratories
(BL/6J) have a loss-of-function mutation in the gene encoding
the Nnt by the missense of exons 7–11, accounting for glucose
intolerance of this strain (Toye et al., 2005). In pancreatic islet
cells exposed to high glucose, deletion of the Nnt led to oxidative
stress and impaired ATP production and insulin release
(Freeman et al., 2006; Toye et al., 2005). Furthermore, BL/6J
mice are more sensitive to deletion of Mn2+-dependent superox-
ide dismutase (Mn-SOD) than other strains by developing car-
diomyopathy, which was also related to theNntmutation (Huang
et al., 2006) and ameliorated by re-expressing one wild-type Nnt
allele in BL/6J mice (Kim et al., 2010).
Here, we report that opposite to this prevailing view of the
Nnt as an antioxidative enzyme, it switches to a pro-oxidative
mode in situations of pathologic cardiac workload by reversing
its direction, oxidizing NADPH to regenerate NADH for ATP pro-
duction, but at the cost of the NADPH-dependent antioxidative
capacity. This reverse-mode Nnt reaction increases mitochon-
drial ROS emission and accounts for maladaptive cardiac re-
modeling and mortality in response to pressure overload, while
BL/6J mice lacking a functional Nnt are protected from heart
failure. Since BL/6J is the most commonly used mouse strainCell Mein biomedical research, these data indicate that in numerous
studies that applied cardiac pressure overload in this strain,
oxidative stress was systematically underestimated. Our results
further emphasize the importance of mitochondrial ROS produc-
tion for the progression of heart failure and the feasibility of tar-
geting mitochondria to protect the heart from remodeling and
contractile dysfunction.
RESULTS
Expression and Activity of Nnt and Other NADPH-
Regenerating Enzymes
In agreement with previous studies, exons 7–11 of the gene en-
coding Nnt were missing in BL/6J, but not BL/6N mice (Huang
et al., 2006) (Figure S1A). In BL/6N mice, Nnt protein expression
was highest in the heart, moderate in kidney and liver but absent
from brain and skeletal muscle (Figure S1B). In heart, Nnt was
expressed in myocytes and fibroblasts (Figures S1C and S1D).
In contrast, Nnt expression was absent from any tissue in BL/
6J mice (Figures S1B and S1C). Accordingly, Nnt enzymatic
activity was detected in cardiac, but hardly in brain- and not in
skeletal muscle mitochondria from BL/6N mice, while it was
zero in any mitochondria in BL/6J mice (Figure S1E).
Since mitochondrial NADPH can be regenerated not only by
the Nnt, but also by isocitrate dehydrogenase (IDH2) and malic
enzyme (MEP) (Figure 1A), we ruled out a compensatory upregu-
lation of these enzymes in BL/6J mitochondria (Figures S1F and
S1G). Based on their NADPH-regenerating efficacies, IDH2 has
the highest contribution to overall NADPH regenerating capacity
in cardiac BL/6N mitochondria (70%), followed by Nnt (22%)
and MEP (8%; Figure S1H).
The Nnt mutation in BL/6J was originally discovered by this
strain’s impaired glucose tolerance (Toye et al., 2005). As the
underlying mechanism, glucose-induced oxidative stress in
pancreatic beta cells was reported (Freeman et al., 2006). There-
fore, we compared Nnt activity to IDH2 and MEP activities in
pancreatic islets of BL/6N and BL/6J mice. In the presence of
ATP, which resembles the situation when glucose induces insu-
lin release, IDH2 activity was largely suppressed (Figure S1I). No
relevant amounts of MEP activity were detected under either
condition (not shown). In the presence of ATP, Nnt activity wastabolism 22, 472–484, September 1, 2015 ª2015 Elsevier Inc. 473





Figure 2. Ameliorated Cardiac Remodeling and Oxidative Stress in BL/6J Compared to BL/6N Mice
BL/6N and BL/6J mice were exposed to TAC or sham-surgery for 6 weeks.
(A) Heart weight (HW) to tibia length ratio.
(B) Lung fluid; pulmonary congestion was defined as >0.2 ml. The percentages indicate the fraction above this threshold. *p < 0.05 (Fisher’s exact test).
(C) LV ejection fraction (LVEF) determined in isolated working hearts.
(D) LV expression of ANP mRNA.
(E) Representative histological images of fibrosis in LV myocardium.
(F) Quantification of fibrosis.
(G) Quantification of myocyte cross-sectional area in the LV.
(H) Representative 8-OHdG staining of LV nuclei as index for intracellular ROS.
(I) Quantification of 8-OHdG staining in LV cardiac myocytes.
(J) Correlation between 8-OHdG staining and fibrosis.
(legend continued on next page)
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higher than IDH2 activity and therefore the dominating enzyme
with NADPH-regenerating capacity under these conditions (Fig-
ures S1I and S1J).
Nnt Contributes to NADPH Regeneration and ROS
Elimination during a Physiological Workload Increase
To examine the functional consequences of Nnt deficiency for
mitochondrial ROS formation, isolated cardiac myocytes were
exposed to the b-adrenergic agonist isoproterenol and an
increased stimulation rate (Figure 1B). This induced similar
increases of sarcomere shortening, cytosolic and mitochondrial
Ca2+ without any differences between BL/6N and BL/6J
myocytes (Figures 1B, 1C, and S1K–S1L). Furthermore, DJm
remained stable during the protocol without differences be-
tween strains (Figure 1D). Electrical stimulation per se increased
mitochondrial ROS formation (Figures 1E and 1F). While no dif-
ferences in dO2
 formation were observed between strains,
H2O2 (and presumably also other ROS due to the limited speci-
ficity of DCF to H2O2) increased in BL/6J versus BL/6Nmyocytes
during the workload transition (Figures 1E and 1F). These data
are in agreement with the concept that during a physiological
increase in workload triggered by b-adrenergic stimulation, the
Nnt contributes to NADPH regeneration to fuel H2O2-detoxifying
enzymes (Figure 1A).
Ameliorated Cardiac Remodeling in BL/6J versus BL/6N
Mice after Pressure Overload
Since mitochondrial ROS production plays an important role for
cardiac remodeling in response to pressure overload (Dai et al.,
2012), we speculated that the lack of Nnt in BL/6J mice should
aggravate the development of heart failure 6 weeks after trans-
verse-aortic constriction (TAC). However, TAC led to similar in-
creases in heart weight in both strains (Figure 2A), and against
our expectations, pulmonary congestion (indicating cardiac
decompensation) was more frequent in BL/6N than in BL/6J
mice (Figure 2B). Isolated working heart analyses revealed
decreased left ventricular (LV) ejection fraction (Figure 2C) and
elevated LV volume at 70 mmHg end-systolic pressure (inte-
grating systolic dysfunction with LV enlargement; Figure S2A)
in BL/6N, but not BL/6J mice after TAC. Accordingly, mRNA
expression of atrial natriuretic peptide (ANP), an index of LV
filling pressures, was substantially increased after TAC in BL/
6N and ameliorated in BL/6J mice (Figure 2D). Also, the increase
in LV fibrosis was more pronounced in BL/6N than BL/6J mice
(Figures 2E and 2F) despite similar increases in myocyte cross
sectional area (Figure 2G).
To understand the underlying mechanisms for these unex-
pected results, we analyzed nuclear staining of 8-hydroxy-
20-deoxyguanosine (8-OHdG) in LV myocardium as an indicator
of intracellular ROS formation. In sham-operated animals,
8-OHdG staining was slightly elevated in BL/6J compared to
BL/6N mice (Figures 2H and 2I). In stark contrast, TAC substan-
tially increased 8-OHdG staining in myocytes and non-myocytes(K) Venn plot diagram indicating the numbers of genes changed after TAC versu
(L) mRNA expression of CTGF in the LV.
(M) Correlation between CTGF expression and 8-OHdG staining.
Data are presented as means ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.0001 (one-
columns. See also Figure S2.
Cell Mefrom BL/6N, but not BL/6J hearts (Figures 2H, 2I, and S2B). The
levels of oxidative stress correlated with the degree of fibrosis,
cardiac hypertrophy, ANP upregulation, and pulmonary conges-
tion in BL/6N mice (p < 0.01, respectively), while these correla-
tions were lost in BL/6J mice (Figure 2J and data not shown).
To gain further insight into the mechanisms of remodeling,
we performed gene array analyses. When applying a p value of
<0.05 and a threshold of at least a 2-fold change, 148 genes
were differentially regulated by TAC versus sham in BL/6N
mice, while only 33 genes were differentially regulated in BL/6J
mice (Figure 2K; Tables S1 and S2). Of these 33 genes, 26 were
also regulated in BL/6N mice (Figure 2K), indicating similar, but
clearly ameliorated TAC-induced genomic remodeling in BL/6J
mice. Accordingly, pathway analyses revealed upregulation of
cardiac hypertrophy and fibrosis pathways in BL/6N (p < 0.001,
respectively; data not shown), but not BL/6J mice after TAC.
Of the fibrotic pathways, the most consistent change in BL/6N
mice after TAC was of the gene encoding connective tissue
growth factor (CTGF), which is inducible by H2O2 (Park et al.,
2001). Real-time PCR confirmed strong upregulation of CTGF
after TAC in BL/6N, which was blunted in BL/6J mice (Figure 2L).
CTGF upregulation correlated closely with oxidative stress in
hearts from BL/6N, but not BL/6J mice (Figure 2M). In contrast,
other genes involved in fibrosis were not differentially regulated
(Figures S2C and S2D).
An Unexpected Yin-Yang Role of the Nnt for the
Regulation of Mitochondrial ROS
The analyses of 8-OHdG in LV myocardium (Figures 2H and 2I)
indicate that in response to a pathological increase in cardiac
afterload, oxidative stress is more pronounced in BL/6N than in
BL/6J mice. Given that the Nnt is viewed as an antioxidative
enzyme (Rydstro¨m, 2006), supported by our results in cardiac
myocytes during a physiological workload transition (Figures
1A and 1F), this appeared paradoxical. Thus, we challenged
our initial hypothesis and reasoned that under different meta-
bolic conditions, the direction of the Nnt reaction may vary.
A physiological workload transition (triggered by b-adrenergic
activation) increases Ca2+ and activates the Krebs cycle,
compensating the ETC-induced oxidation of NADH (‘‘parallel
activation’’; Figure 1A) (Cortassa et al., 2006; Maack et al.,
2006). In contrast, when increasing preload in isolated cardiac
trabeculae, contractile force (and consequently ATP consump-
tion) increase via the Frank Starling mechanismwithout a parallel
increase in Ca2+ (Backx and Ter Keurs, 1993). Accordingly,
increasing preload in cardiac trabeculae oxidizes NAD(P)H
to NAD(P)+ without a compensatory Ca2+-induced regeneration
(Brandes and Bers, 1997). We therefore reasoned that the
in vitro conditions in un-stretched myocytes performing low
levels of mechanical work, but with high Ca2+-stimulated Krebs
cycle activity (Figure 1) may be opposite to the in vivo conditions
after TAC, with high mechanical workload without Ca2+-induced
‘‘parallel activation’’ of the Krebs cycle.s sham in BL/6N and BL/6J mice, applying a p < 0.05 and >2-fold change.
way ANOVA, Tukey’s post test). Replicates (n) are displayed as numbers in the
tabolism 22, 472–484, September 1, 2015 ª2015 Elsevier Inc. 475
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Figure 3. Accelerating Respiration Induces Reverse-Mode Nnt Reaction
(A) O2 consumption in isolated cardiac mitochondria supplied with pyruvate/malate (5/5 mM) in the absence (State 4) and presence of ADP (1 mM; State 3). RCR,
respiratory control ratio.
(B) Mitochondrial dO2
 formation determined by EPR.
(C) Mitochondrial emission of H2O2 determined by Amplex Ultra-Red.
(D) ADP-induced oxidation of NAD(P)H autofluorescence. AU, arbitrary units.
(E) Accelerating NADH-coupled respiration (by ADP or FCCP) induces reverse-mode Nnt, oxidizing NADPH, GSH, and TRX/PRX, and increasing H2O2 emission.
(F and G) Autofluorescence of NAD(P)H/NAD(P)+ and FADH2/FAD in isolated cardiac myocytes from BL/6N (F) and BL/6J (G) mice exposed to FCCP (5 mM),
cyanide (4 mM), and H2O2 (10 mM), respectively.
(H) Quantification of the FCCP- and H2O2-sensitive pools of NAD(P)H/NAD(P)
+, calculated from data in (F) and (G).
(I) NAD(P)H plotted against DJm in response to FCCP/oligomycin.
(J) Fluorescence decay rate (tbound) of NAD(P)H reporting bound NADPH/NADH in the absence (Con; n = 5, 21 images) and presence of FCCP (5 mM; n = 3, 16
images) or cyanide (4 mM; n = 1, 8 images), respectively.
(K) NADPH/NADH during FCCP divided by NADPH/NADH during cyanide as an index for NADPH uncoupling from the NADH pool.
Data are presented as means ± SEM. **p < 0.01, ***p < 0.001 versus State 4 (paired t test). yp < 0.05, zp < 0.01 versus BL/6 (unpaired t test). xp < 0.05 (one-way
ANOVA, Tukey’s post test). See also Figure S3.To simulate such a pathological workload transition, we
applied ADP to isolated cardiac mitochondria in the absence
of Ca2+. In agreement with the prevailing paradigm of mitochon-
drial ROS production (Balaban et al., 2005), ADP accelerated O2
consumption and lowered dO2
 formation (detected by EPR spin
trap), without any differences between strains (Figures 3A and
3B). In contrast, ADP did not reduce H2O2 emission from BL/
6N mitochondria (detected by Amplex Ultra-Red assay),
whereas in BL/6J mitochondria, H2O2 emission was reduced
by a similar degree as dO2
 formation (by 36%, respectively; Fig-
ures 3B and 3C). Indeed, this was opposite to the results in iso-
lated myocytes exposed to b-adrenergic stimulation (Figure 1F),
where ROS emission was higher in BL/6J than in BL/6N myo-
cytes. In contrast, in mitochondria from brain and skeletal mus-
cle of BL/6N mice, in which no Nnt activity was detected (Fig-
ure S1E), ADP lowered H2O2 emission to a similar extent as
dO2
 without differences between strains (Figures S3A–S3F).
Reverse-Mode Nnt Oxidizes NADPHwhen Respiration Is
Accelerated
Based on these opposing observations, we formulated the
following hypothesis: accelerating respiration with ADP oxidizes476 Cell Metabolism 22, 472–484, September 1, 2015 ª2015 ElsevieNADH, and if NADH is not sufficiently regenerated by the Krebs
cycle, NAD+ provides a substrate for the reverse reaction of the
Nnt, which is further facilitated by high NADPH, low NADH, and
ADP-induced dissipation of DmH (Figure 3E). This reversal of the
Nnt oxidizes NADPH to regenerate NADH,which is consumed by
the ETC. In fact, oxidation of the overall NAD(P)H/NAD(P)+ redox
pool by ADP was more pronounced in BL/6N than BL/6J mito-
chondria (Figure 3D).
To interrogate this further, wemeasuredmitochondrial NAD(P)
H/NAD(P)+ and FADH2/FAD redox states in isolated cardiac my-
ocytes and exposed them to the uncoupler FCCP, the complex
IV inhibitor cyanide and external H2O2 (Figure 3F). Similar to ADP,
FCCP accelerates respiration (by dissipating DmH) and thereby
oxidizes NADH. While cyanide completely reduced the redox
states of NAD(P)H/NAD(P)+ and FADH2/FAD, H2O2 completely
oxidized both NADPH and NADH independent of the presence
of Nnt.
In fact, FCCP led to an identical oxidation of the overall NAD(P)
H/NAD(P)+ redox pool as H2O2 in BL/6Nmyocytes (Figure 3F). In
contrast, in BL/6J myocytes, the oxidation of NAD(P)H/NAD(P)+
by FCCP was less pronounced than by H2O2 and less than by
FCCP in BL/6N myocytes (Figures 3F and 3G). The redox stater Inc.
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Figure 4. Computational Modeling Indicates
Reversal of Nnt during NADH Oxidation
(A–E) A computational two-compartment model
(Kembro et al., 2013) integrating mitochondrial
energetics with redox regulation was used to
assess the effect of transient increases in extra-
mitochondrial ADP from 5 to 20, 30, and 40 mM
ADP, respectively, on (A) mitochondrial [ADP], (B)
DJm, (C) mitochondrial [NADH], (D) Nnt activity,
and (E) mitochondrial [NADPH].
(F) Changes in [NADH] and [NADPH] together with
Nnt activity in response to a step increase from 5 to
30 mM [ADP] at higher temporal resolution.
Green/red shaded areas indicate forward/reverse-
mode Nnt activity, respectively.of FADH2/FAD in the same cells (Figures 3F and 3G, lower traces)
served to control for the redox state of the ETC, which should
parallel the behavior of NADH (but not NADPH). These results
suggest that despite FCCP-induced oxidation of NADH, NADPH
is conserved in BL/6J mitochondria in the absence of a reverse-
mode Nnt reaction. Maintained NADPH (and H2O2 eliminating
capacity) in BL/6J mitochondria during accelerated NADH-
coupled respiration could explain why in the presence of
ADP, H2O2 was lowered by the same degree as dO2
 in isolated
mitochondria (i.e., by 36%; Figures 3B and 3C). Comparison of
the absolute H2O2- and FCCP-sensitive fluorescence of the
NAD(P)H/NAD(P)+ redox pool indicates that (1) the pool sizes
per se were not different between BL/6N and BL/6J mitochon-
dria, and (2) NADPH contributes 23% and NADH 77% to
this fluorescence (Figure 3H).
Since the Nnt is coupled to DmH, a reversal of the Nnt should
also reverse the direction of proton translocation across the
inner mitochondrial membrane, thereby possibly contributing
to DJm (Figure 3E). In fact, when accelerating respiration in
isolated myocytes with FCCP, DJm dissipated slightly faster
in BL/6J than in BL/6N myocytes (Figures S3G and S3H), indi-
cating that reverse-mode Nnt might delay dissipation of DJm
by consuming NADPH. Similar results were obtained when
Nnt was inhibited acutely with a chemical inhibitor (NBD-chlo-
ride) in BL/6N myocytes (Figures S3I and S3J). Despite this
slight delay, DJm was dissipated by similar extents in myo-
cytes from BL/6N and BL/6J mice. In agreement with this,
steady-state DJm was unchanged in isolated and energized
BL/6N and BL/6J mitochondria after titration of the uncoupler
DNP, in the absence or presence of nigericin (that dissipates
DpH, but not DJm; Figures S3K and S3L), suggesting that
the overall contribution of reverse-mode Nnt to DJm is rather
small.
In isolated cardiac myocytes, for any given DJm during
FCCP-induced dissipation, the redox state of NAD(P)H/
NAD(P)+ remained more reduced in BL/6J than in BL/6N
mitochondria (Figure 3I), further supporting that Nnt-deficiency
may maintain NADPH during accelerated respiration. To test
this further, we employed fluorescence lifetime imagingCell Metabolism 22, 472–484, S(FLIM), where the longer time constant
of NAD(P)H fluorescence decay (tbound)
reflects the ratio of bound NADPH to
NADH (Blacker et al., 2014). In agree-ment with previous data on HEK cells, FCCP did not change
tbound in BL/6N myocytes (Figure 3J), since NADH and
NADPH are oxidized by FCCP to similar extents, presumably
through equilibration of both pools via the Nnt (Blacker
et al., 2014). In contrast, FCCP caused a small but significant
increase in tbound in BL/6J myocytes, indicating more pro-
nounced oxidation of NADH than NADPH (Figure 3J). Vice
versa, blocking the ETC with cyanide reduces the redox state
of NADH, and since the total pool of NADH is larger than the
NADPH pool, tbound shifts further toward the value predicted
for purely NADH (1.5 ns; Figure 3J). This was even more
pronounced in BL/6J myocytes, where a lack of forward-
mode Nnt may hinder complete NADPH reduction. Therefore,
when dividing the estimated NADPH/NADH ratios after FCCP
by the ratios after cyanide, respectively, the greater values in
BL/6J myocytes indicate that the NADPH pool is more ‘‘un-
coupled’’ from the NADH pool (compared to BL/6N; Figure 3K),
consistent with a lack of Nnt-mediated equilibration of NADH
and NADPH pools in either direction and supporting the idea
that NADPH is relatively conserved after oxidation of NADH
by FCCP.
Furthermore, we performed computational modeling using
a two-compartment model that integrates mitochondrial ener-
getics with redox regulation (Kembro et al., 2013). Starting from
low extra-mitochondrial [ADP] of 5 mM, transient increases of
[ADP] to 20, 30, and 40 mM increased mitochondrial [ADP] (Fig-
ure 4A), dissipated DJm and oxidized NADH (Figures 4B and
4C). While at low [ADP], the Nnt operated in the forward mode,
it reversed direction during NADH oxidation, inducing NADPH
oxidation (Figures 4D and 4E). Reducing Nnt activity 10,000-
fold prevented NADPH oxidation (Figure 4E) despite similar
NADH oxidation and DJm dissipation (Figures 4B and 4C). Of
note, theNnt reverses already early after initiation ofNADHoxida-
tion, however, the impact on NADPH becomes particularly rele-
vant at strongly oxidizedNADH levels (Figure 4F). Together, these
data imply that acceleration of NADH-coupled respiration dur-
ing metabolic perturbations facilitates Nnt-mediated NADPH
oxidation, while Nnt-deficiencymaintains the NADPH pool under
these conditions.eptember 1, 2015 ª2015 Elsevier Inc. 477
Figure 5. Increasing Afterload Induces Nnt-Mediated Oxidation of Glutathione and Peroxiredoxin
Isolated working hearts from BL/6N and BL/6J mice were held at a preload of 10 mmHg and afterload of 80 mmHg (400 bpm). Afterload was increased to
120 mmHg (AL) or maintained at 80 mmHg (Con). After 15 min, hearts were snap-frozen for biochemical analyses.
(A–D) Representative pressure-volume loops (A), concentration of reduced glutathione (GSH) (B) and oxidized glutathione (GSSG) (C), and ratio of GSH/GSSG (D),
respectively (n = 5 per group).
(E) Degree of oxidation of GSH/GSSG by AL in BL/6N and BL/6J hearts.
(F) Representative western blot determining expression of oxidized peroxiredoxin (Prx-SO3) and calsequestrin (CSQ) in BL/6N and BL/6J hearts, respectively.
(G) Quantification of Prx-SO3 relative to CSQ expression and normalized to Con in BL/6N hearts.
(H) Relative increase of Prx-SO3 in response to AL (fold change of BL/6N Con).
(I) Western -blot analysis of monomeric and dimeric peroxiredoxin III. Red. Con, reduced Control.
(J) Quantification of dimeric/monomeric peroxiredoxin III.
(K) Quantification of malondialdehyde (MDA) concentrations.
Data are presented as means ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (ANOVA, Tukey’s post test); yp < 0.05, zp < 0.01 (unpaired t test; all groups n = 5).Reverse-Mode Nnt Oxidizes Glutathione and
Peroxiredoxin in Response to Increased Afterload
To test the relevance of reverse-mode Nnt on the whole organ
level, we performed experiments on isolated working hearts
exposed to a physiological pre- and afterload of 10 and
80 mmHg, respectively. Under these conditions, the redox
states of glutathione and peroxiredoxin, which are regenerated478 Cell Metabolism 22, 472–484, September 1, 2015 ª2015 Elsevieby NADPH (Figure 1A), were slightly more oxidized in BL/6J
versus BL/6N hearts (Figures 5C, 5D, 5F, and 5G). In contrast,
when afterload was increased from 80 to 120 mmHg for
15 min (Figure 5A), it led to stronger oxidation of glutathione
and peroxiredoxin in BL/6N versus BL/6J hearts (Figures
5B—5H). Reduced peroxiredoxin exists in a monomeric

















Figure 6. Decreased Mortality and Necrosis
in BL/6J Mice after Pressure Overload
BL/6N and BL/6J mice were exposed to a com-
bined operation of TAC or sham plus implantation
of aminipump releasing SS-31 (3mg/kg per day) or
vehicle (NaCl 0.9%) for 6 weeks (A–F) or 3 days
(G–I), respectively.
(A) Kaplan-Meier survival curves in Sham- or TAC-
treated BL/6N mice, treated with SS-31 or vehicle,
respectively.
(B) Kaplan-Meier survival of same groups as in (A),
but in BL/6J mice.
(C) Comparison of Kaplan-Meier survival curves in
TAC/vehicle-treated BL/6N and BL/6J mice.
(D) MDA concentrations in Sham- or TAC-treated
BL/6N mice, the latter treated with vehicle or
SS-31.
(E) Same as in (D), but in BL/6J mice.
(F) Comparison of the absolute increase in MDA in
BL/6N (N) and BL/6J mice (J).
(G) Histological analyses of Evans blue staining in
Sham- and TAC-treated BL/6N and BL/6J mice
(vehicle groups), respectively.
(H) Quantification of Evans Blue staining. Sh,
Sham.
(I) Caspase-3 and caspase-7 activities in the same
groups as in (H).
(J) GSH/GSSG in isolated Langendorff-perfused
BL/6N hearts exposed to H2O2.
(K) Time to 50% dissipation of DJm (TMRM) in
isolated BL/6N cardiac myocytes exposed to
100 mmol/l H2O2, in the absence (H2O2) and pres-
ence of cyclosporine A (CsA; 10 mM) or SS-31
(10 nM), respectively.
Data are presented as means ± SEM. *p < 0.05,
**p < 0.01, and ***p < 0.001 (one-way ANOVA,
Tukey’s post test). yp < 0.05 (unpaired t test). See
also Figure S4.2009). Upon afterload elevation, the degree of dimerization of
the mitochondrial isoform peroxiredoxin III was increased in
BL/6N, but not BL/6J hearts (Figures 5I and 5J), further pin-
pointing mitochondria as the main source for oxidative stress
under these conditions. Accordingly, afterload-induced in-
creases in lipid peroxidation were more pronounced in BL/
6N than in BL/6J hearts (Figure 5K). Taken together, these
data are in good agreement with the in vivo data (Figures
2H and 2I), where ROS levels were slightly lower in sham-
operated-, but much higher in TAC-operated BL/6N versus
BL/6J mice.Cell Metabolism 22, 472–484, STargeting Mitochondrial ROS
Production Reduces Necrosis and
Early Mortality in Response to
Increased Afterload In Vivo
To analyze whether mitochondrial ROS
production is the key difference between
BL/6N and BL/6J mice in response to
increased afterload, we combined TAC
or sham-operation with the implantation
of osmotic minipumps releasing either
vehicle or SS-31, a tetrapeptide that re-
duces mitochondrial ROS production(Szeto, 2014). Vehicle-treated BL/6N mice suffered 50% mor-
tality in 6weeks, whilemost BL/6Jmice survived this intervention
(Figures 6A–6C). SS-31 reduced TAC-inducedmortality in BL/6N
mice to levels of vehicle-treated BL/6J mice (Figures 6A and 6B).
Although TAC-induced increases in lipid peroxidation weremore
pronounced in BL/6N than in BL/6J mice and sensitive to SS-31
(Figures 6D–6F), no differences in cardiac hypertrophy were
observed between strains and by treatment (Figures S4A and
S4B). Despite a mortality-induced selection bias, SS-31 amelio-
ratedANP upregulation inBL/6Nmice,while the TAC-induced in-
crease inCTGFwas insensitive to SS-31 (Figures S4C and S4D).eptember 1, 2015 ª2015 Elsevier Inc. 479
Mitochondrial ROS can trigger the opening of the permeability
transition pore (PTP), dissipate DJm, and induce apoptotic and/
or necrotic cell death (Halestrap, 2005). After only 3 days of TAC,
necrotic cell death increased in hearts of TAC-operated BL/6N,
but not BL/6J mice (Figure 6G). For any given increase in ANP
expression as an index of hemodynamic load, TAC-induced
necrosis was 4- to 5-fold more pronounced in BL/6N mice
than in BL/6J mice (not shown), and this was prevented by SS-
31 (Figure 6H). Similar, albeit less pronounced results were ob-
tained for the activities of caspase-3 and caspase-7 as inducers
of apoptosis (Figure 6I). The PTP inhibitor cyclosporin A reduced
necrosis in TAC-treated BL/6N hearts (to 1.3% ± 0.4%). How-
ever, due to a slight anti-necrotic effect of the oil-based vehicle,
this effect was not significantly different from its control (not
shown). Further experiments on isolated mitochondria revealed
that ameliorated necrosis in BL/6J mice was not related to modi-
fied properties of the PTP per se, since Ca2+ and ROS induced
similar PTP opening in both strains (Figures S4E and S4F).
To test whether the levels of oxidative stress that occur after
TAC in BL/6Nmice are sufficient to induce cardiomyocyte death,
we exposed isolated perfused BL/6N hearts to increasing
concentrations of exogenous H2O2 and observed that 100 mM
H2O2 oxidized the glutathione pool by 40% (Figure 6J), a similar
extent as after increasing afterload from 80 to 120 mmHg in
working hearts (41%; Figure 5D). Applying 100 mM H2O2 to iso-
lated BL/6N cardiomyocytes dissipated DJm by 50% after
12 min, which was delayed by cyclosporin A and even more
by SS-31 (Figure 6K).
Re-expression of the Nnt in BL/6J Mice Re-establishes
Oxidative Stress in Response to Pressure Overload
To rule out that other genomic differences between BL/6N and
BL/6J mice (Simon et al., 2013) account for differential ROS pro-
duction, we obtained BL/6J mice that harbor one allele with the
intact wild-type (wt) and one with the truncated (t) Nnt gene
(BL/6J-Nntwt/t) (Kim et al., 2010). From this strain, we gener-
ated BL/6J-Nntt/t, BL/6J-Nntwt/t, and BL/6J-Nntwt/wt mice. Re-
expression of intact Nnt in BL/6J mice increased Nnt activity to
levels observed in BL/6N mice (Figure 7A). Three days after
TAC, mRNA expression of brain natriuretic peptide (BNP), an
index of LV filling pressures, increased (Figure 7B), together
with more pronounced oxidation of peroxiredoxin and oxidative
stress (indexed by 8-OHdG) in wild-type Nnt-expressing mice
in vivo (Figures 7C–7F). For any given TAC-induced increase of
cardiomyocyte cross sectional area, the increase in ROS in vivo
was higher in BL/6J-Nntwt/wt mice compared to BL/6J-Nntt/t or
BL/6J-Nntwt/t (Figure 7G). Taken together, these data indicate
that the lower TAC-induced mitochondrial ROS emission in BL/
6J mice was primarily related to the absence of a functional Nnt.
DISCUSSION
Our study revealed that besides its canonical antioxidant func-
tion, the mitochondrial transhydrogenase (Nnt) can switch to a
pro-oxidative reverse mode that triggers NADPH oxidation dur-
ing a pathological increase of workload in cardiac mitochondria
(Figure 7H). This pro-oxidative shift provokes mitochondrial
ROS emission and induces necrotic cell death, fibrosis, cardiac
dysfunction, and death. To our knowledge, this is the first bona480 Cell Metabolism 22, 472–484, September 1, 2015 ª2015 Elseviefide mechanism that explains how a pathological increase in
cardiac workload per se increases mitochondrial ROS emission
independent of neuroendocrine activation. The missense of a
functional Nnt in BL/6J mice substantially ameliorates oxidative
stress, maladaptive remodeling, and LV dysfunction and re-
duces death in response to pressure overload. This finding has
broad implications since it sheds new light on many previous
studies using this strain to analyze the consequences of other,
non-mitochondrial sources of ROS for cardiac remodeling
and the development of heart failure. Furthermore, differential
tissue-specific expression of the Nnt adds another level of
complexity to the regulation of mitochondrial ROS emission in
different tissues under variable metabolic conditions. Finally,
targeting mitochondrial ROS production with the tetrapeptide
SS-31, which is already in clinical testing, may be an efficient
therapy of heart failure.
Pathophysiological Role of Mitochondrial ROS in Heart
Failure
Oxidative stress in the plasma and myocardium of patients with
heart failure correlates with LV dysfunction (Belch et al., 1991;
Maack et al., 2003). Besides mitochondria, other relevant ROS
sources in cardiac myocytes are NADPH oxidases, uncoupled
nitric oxide synthases, monoamine oxidase A, and xanthine
oxidase. The relative contribution of these sources to overall
myocardial ROS production during the development of heart fail-
ure, however, is unknown. A common approach to estimate the
role of a particular ROS source is to apply TAC in mice with ge-
netic modifications of proteins involved in ROS production. In
fact, most of these studies were performed on BL/6J mice (Table
S1). Our data indicate that in BL/6J mice, contribution of mito-
chondria to cellular ROS production, and maladaptive remodel-
ing in response to TAC is heavily underestimated or even absent
(Figure 2I), implying that studies using BL/6J may overestimate
the contribution of non-mitochondrial ROS sources. In contrast,
overexpressing a mitochondria-targeted catalase in BL/6N mice
protected hearts from maladaptive remodeling in response to
TAC (Dai et al., 2012). Since in our study, inhibiting mitochondrial
ROS emission with the tetrapeptide SS-31 rescued TAC-
inducedmortality in BL/6N, but not BL/6J mice, these data imply
that mitochondria are the dominant source of ROS during path-
ological elevations of afterload. In humans, chronic elevations of
afterload are a central feature of various cardiovascular dis-
eases, such as arterial hypertension, aortic stenosis or vascular
stiffness imposed by atherosclerosis and/or aging. All these age-
associated conditions are known risk factors for the develop-
ment of heart failure. A previous study observed downregulation
of Nnt activity in human failing hearts, which was associated with
oxidation of glutathione (Sheeran et al., 2010). While these
authors suggested that downregulation of Nnt activity may
contribute to oxidative stress, the data of our study rather imply
that Nnt downregulation in human heart failuremay be protective
by reducing reverse-mode Nnt-mediated mitochondrial ROS
emission.
Already 3 days after TAC, the rates of apoptosis and necrosis
were strikingly different between strains. In human heart failure,
the levels of apoptosis are increased (Olivetti et al., 1997), and
even low rates of cardiomyocyte death are sufficient to cause a
lethal dilated cardiomyopathy (Wencker et al., 2003). In humanr Inc.
Figure 7. Re-expression of Nnt in BL/6J Mice Increases Oxidative Stress In Vivo
(A) Nnt activity in BL/6N and BL/6J mice, compared with N5 BL/6J-Nntt/t mice (with two alleles of the truncated (t) Nnt gene) and mice with heterozygous
(BL/6J-Nntwt/t) and homozygous re-expression of the wild-type Nnt gene (BL/6J-Nntwt/wt). Inset: western blot analysis of Nnt and GAPDH in mouse LV as
indicated.
(B) mRNA expression of BNP in LV of BL/6J-Nntt/t, BL/6J-Nntwt/t and BL/6J-Nntwt/wt mice after sham or TAC surgery, respectively.
(C) Western blot analysis of oxidized peroxiredoxin (Prx-SO3) and GAPDH in LV of BL/6J-Nnt
t/t and BL/6J-Nntwt/t mice after sham or TAC surgery, respectively.
(D) Quantification of data in (C).
(E) Representative histographs of 8-OHdG staining in LV of BL/6J-Nntt/t, BL/6J-Nntwt/t, and BL/6J-Nntwt/wt mice after TAC, respectively.
(F) Quantification of data in (E).
(G) Plotting of 8-OHdG staining against myocyte cross sectional area in BL/6J-Nntt/t, BL/6J-Nntwt/t, and BL/6J-Nntwt/wt mice after TAC, respectively.
(H) Scheme of proposed mode of action of Nnt during physiological and pathological cardiac workloads.
Data are presented as means ± SEM. *p < 0.05, **p < 0.01, and ***p < 0.001 (ANOVA, Tukey’s post test).heart failure, elevated levels of high-sensitive troponin T, amarker
for cardiomyocyte necrosis, predict an adverse clinical outcome
(Masson et al., 2012). SS-31 accumulates in mitochondria and
protects cardiolipin and other mitochondrial proteins from oxida-
tive damage, which may interrupt a feed-forward pathway of
mitochondrial dysfunction and ROS production (Dai et al.,
2013; Szeto, 2014). In our study, SS-31 prevented necrosis and
(partly) apoptosis, while CTGF upregulation appeared unaf-
fected. These data are in agreement with, and at the same time
extend, previous data in which SS-31 prevented 84% of TAC-
induced proteomic remodeling in BL/6N mitochondria (Dai
et al., 2013). Ongoing clinical studies will have to verify whether
SS-31 is of clinical use in patients with heart failure (Szeto, 2014).Cell MeReverse-Mode Nnt Modifies Current Paradigm of
Mitochondrial ROS Production
The current paradigm of mitochondrial ROS production implies
that dissipatingDJmbyaccelerating respirationwithADP (or acti-
vation of uncoupling proteins) generally reduces mitochondrial
oxidative stress (Balaban et al., 2005). In contrast, we observed
that H2O2 emission was lowered by ADP only in the absence of
an Nnt in BL/6J, but not BL/6N cardiac mitochondria. This is in
seeming contrast to other studies on which the current paradigm
is based on. For instance, in isolated rat cardiac mitochondria,
H2O2 emission decreased when respiration was accelerated by
ADP or chemical uncoupling (Korshunov et al., 1997). In that
study, however, the mitochondrial H2O2-scavenging capacitytabolism 22, 472–484, September 1, 2015 ª2015 Elsevier Inc. 481
was eliminated by pretreatment of mitochondria with H2O2 and
aminotriazole, so that H2O2 emission was governed primarily
by dO2
 production at the ETC and no longer counterbalanced
by NADPH-dependent H2O2 elimination. Furthermore, H2O2
emission from brain mitochondria wasmaximal at reduced redox
states of NAD(P)H, while chemical or ADP-induced uncoupling
of DJm lowered it (Starkov and Fiskum, 2003). However, brain
mitochondria do not express the Nnt (Figure S1B), and we
could reconcile their findings in brain mitochondria from BL/6N
mice, where ADP reduced H2O2 emission to a similar extent
as in brain mitochondria from BL/6J mice (Figure S3). Taken
together, differential Nnt expression accounts for tissue-specific
differences in the regulation of mitochondrial ROS emission
that may also explain why in contrast to results on brain mito-
chondria (Starkov and Fiskum, 2003), we previously observed
an inverse (and not positive) correlation between the redox state
of NAD(P)H and H2O2 emission in cardiac myocytes (Kohlhaas
et al., 2010).
Organ-Specific Relevance of Nnt for Antioxidative
Capacity
Interestingly, under physiological (unstressed) conditions,
impaired glucose tolerance due to ROS-dependent impairment
of insulin release is so far the only known phenotype provoked
by the mutation of the Nnt in BL/6J mice (Simon et al., 2013;
Toye et al., 2005). One explanation may be that the high effi-
cacy of IDH2 to regenerate NADPH (Figures S1F and S1H)
can compensate for the loss of the Nnt at least in cardiac mito-
chondria. In contrast, in pancreatic islets from BL/6N and BL/
6J mice we observed that in the presence of physiological
levels of ATP, IDH2 activity was largely suppressed (Figures
S1I and S1J). Thus, when high glucose triggers an elevation
of ATP and insulin secretion in the pancreas, the lack of Nnt
in BL/6J may deteriorate the NADPH regenerative capacity
and induce oxidative stress to a higher extent in this organ
compared to other organs in which IDH2 can compensate for
the loss of Nnt.
Limitations
Since we did not apply knockout technology, we cannot fully
rule out that apart from Nnt expression, also other genetic dif-
ferences between BL/6N and BL/6J mice may contribute to the
differences in oxidative stress and/or maladaptive remodeling
between the strains. However, since (1) re-expression of one
or two wild-type Nnt alleles in BL/6J mice re-increased oxida-
tive stress after TAC (Figure 7), and (2) no differences in mito-
chondrial dO2
 production or H2O2 emission were observed be-
tween the strains in the absence of ADP (State 4; Figures 3B
and 3C), other mechanisms than differential Nnt expression
appear unlikely to account for the differences in ROS emission
when ADP accelerates respiration at higher workloads. Another
limitation is that NADPH could not be measured directly and
separated from fluorescent NADH signals, which is technically
challenging. Nevertheless, the information gathered from
NADPH/NADH ratios determined by FLIM (Figures 3J and 3K)
during mitochondrial perturbations and data from computa-
tional modeling (Figure 4) support the concept that oxidation
of NADH at the ETC can provoke the reverse mode of the
Nnt to oxidize NADPH.482 Cell Metabolism 22, 472–484, September 1, 2015 ª2015 ElsevieConclusions
We identified a mechanism that couples a pathological increase
in metabolic demand to increased mitochondrial ROS emission
in the heart (Figure 7H). The discovery of the previously unappre-
ciated reverse-mode of the Nnt assigns this enzyme a dual role
serving either pro- or antioxidative processes depending on
the metabolic state of a cell. Considering the overarching impor-
tance of ROS production in aging and aging-related diseases,
these data provide important new insights into the mechanisms
of redox regulation under physiological and pathological condi-
tions in various tissues. Targeting mitochondrial ROS emission
is therefore a promising approach to ameliorate aging-related
diseases and in particular, heart failure.
EXPERIMENTAL PROCEDURES
Animal Experiments
Animal procedures were approved by the local animal ethics committee and
conducted in accordance with institutional guidelines. C57BL/6 mice were ob-
tained from Charles River (BL/6N, C57BL/6NCrl, strain code 027; and BL/J,
C57BL/6J, JAX Mice Stock Number 000664). N5 BL/6J-Nntwt/t mice (Kim
et al., 2010) were obtained from Jackson Laboratories and further bred at
our institution, generating BL/6J-Nntt/t, BL/6J-Nntwt/t and BL/6J-Nntwt/wtmice.
Transaortic Constriction
Transaortic constriction (TAC) was performed as described in more detail in
the Supplemental Experimental Procedures. Mice (10- to 12-week-old) under-
went TAC or sham surgery andwere followed for 6 weeks or 3 days. A literature
research was performed for other studies that performed TAC in normal or
genetically modified BL/6N and BL/6J mice (Table S1). For drug treatment,
osmotic minipumps (Alzet #2006) were implanted 20 min after TAC
and loaded with SS-31 (3 mg/kg 3 d) or vehicle (0.9% NaCl) for 6 weeks. In
3-day experiments, SS-31 was injected intraperitoneally (i.p.) (0.5 mg/ml,
0.9% NaCl) and compared to 0.9% NaCl.
Echocardiography
Echocardiography was performed as described in more detail in the Sup-
plemental Experimental Procedures section on anaesthetized mice using
a Visualsonics Vevo 770 High-Resolution in vivo Micro-Imaging System
(Visualsonics).
Isolated Working Hearts Experiments
For hemodynamics, hearts were mounted in a working heart apparatus and
analyzed with a pressure-volume catheter as described in the Supplemental
Experimental Procedures. Hearts equilibrated at 10 mmHg preload and
80 mmHg afterload at 400 bpm external pacing. Then afterload was increased
to 120 mmHg or maintained at 80 mmHg for 15 min.
Isolated Cardiac Myocytes
Cardiac myocytes were isolated by enzymatic digestion and experiments per-
formed as described in the Supplemental Experimental Procedures and Table
S2. Briefly, adult ventricular myocytes were electrically stimulated at 0.5 Hz
and then exposed to isoproterenol (30 nM) and an increase of stimulation
rate to 5 Hz for 3 min. Sarcomere shortening was detected together with either
(1) the redox state of NAD(P)H/NAD(P)+ and FADH2/FAD by autofluorescence,
(2)DJm (with tetramethylrhodaminemethyl ester; TMRM) together with [Ca
2+]c
(indo-1 acetoxymethyl esther; AM), (3) mitochondrial dO2
 formation (Mito-
SOX), or (4) cellular H2O2 formation (using 5-(-6)-chloromethyl-2,7-dichlor-
ohydrofluorescein di-acetate; CM-H2DCFDA). Using a patch-clamp-based
protocol with application of indo-1 salt and rhod-2 AM, [Ca2+]c was determined
together with [Ca2+]m under similar conditions (Maack et al., 2006).
Quiescent myocytes (Figures 3F and 3G) were exposed to FCCP (5 mM), cy-
anide (4 mM), and H2O2 (10 mM) and NAD(P)H/NAD(P)
+ and FADH2/FAD were
determined in the same cells, respectively. DJm (TMRM) was determined
together with NAD(P)H in myocytes exposed to FCCP (5 mM) and oligomycin
(1.26 mM; Figures S3G–S3J).r Inc.
NAD(P)H Fluorescence Lifetime Imaging Experiments
Cardiac myocytes were allowed to adhere to glass coverslips for >2 hr before
imaging. At the microscope, coverslips were maintained at 37C in a home
built chamber and bathed in DMEM (GIBCO) containing (in mM) glucose 25,
pyruvate 1, glutamine 2, and HEPES 10. NAD(P)H fluorescence lifetime imag-
ing (FLIM) was described previously (Blacker et al., 2014) and in further detail in
the Supplemental Experimental Procedures. Five minutes prior to application
of pharmacological treatments, 10 mM blebbistatin was applied to prevent
contraction during FLIM image acquisition. Control experiments showed
that blebbistatin did not alter the FLIM parameters abound (p = 0.2, n = 3, 14
images), tfree (p = 0.2) or tbound (p = 0.1).
Isolated Mitochondria
Mitochondria were isolated from heart, brain and skeletal muscle by standard
techniques as described in the Supplemental Experimental Procedures. Mito-
chondria were supplied with pyruvate/malate as substrates (5/5 mM). Respira-
tion (Clark electrode), dO2
 formation (electron paramagnetic resonance,
EPR), H2O2 emission (Amplex Ultra-Red), or NAD(P)H autofluorescence
were determined in the absence or presence of ADP (1 mM), respectively.
DJm was determined using triphenylmethylphosphonium (TPMP
+).
Real-Time PCR, Gene Array, and Western Blot Analysis
Real-time PCR, gene array, and western blot analyses were performed by
standard techniques as described in more details in the Supplemental Exper-
imental Procedures. The secondary antibody against Nnt was provided by
Ting-Ting Huang (University of California, San Francisco). Gene array experi-
ments were performed using the Affymetrix GeneChip Mouse Gene 1.0 ST
Array. The gene array accession number of the data in Tables S3 and S4 is
‘‘E-MTAB-2732’’ at ArrayExpress.
Histological Analyses
Histological analyses were performed by standard techniques with details out-
lined in the Supplemental Experimental Procedures. H&E staining was used for
cardiomyocyte morphometry, picrosirius red staining for fibrosis, and 8-hy-
droxy-20-deoxyguanosine (8-OHdG) for intracellular ROS detection. Evans
blue staining (indexing necrosis) was detected after i.p. application of 100 ml
of Evans blue solution (16.7 mg/ml) 1 day before sacrifice.
Enzyme Activities
Details on enzymatic activity measurements are provided in the Supplemental
Experimental Procedures. Activities of Nnt, IDH2, and MEP were analyzed by
NADPH- or APAD-coupled spectrophotometric assays in homogenates of iso-
lated cardiac mitochondria.
GSH/GSSG Measurements
Determination of GSH and GSSG was performed as described previously
(Rahman et al., 2006) and as outlined inmore detail in the Supplemental Exper-
imental Procedures. For GSSG measurements, 3 mM of 1-methyl-2-vinylpyr-
idine was added for derivatization of reduced GSH before homogenization.
Reduced GSH was calculated as the difference between total glutathione
and GSSG.
Malondialdehyde Concentrations
Lipid peroxidation was determined using the ALDetect Lipid Peroxidation
Assay Kit (ENZO Life Science) to detect the concentrations of malondialde-
hydes (MDA) according to the manufacturer’s protocol. As a variation from
that protocol, the sample volume was reduced from 200 ml to 150 ml.
Caspase-3/7 Activity
The Caspase-Glo 3/7 Assay (Promega) was used to measure caspase-3 and
caspase-7 activities. Heart lysates (50 mg) were mixed with reaction solution
at equal volumes in a 96-well plate. Luminescence was detected after
20 min (at 37C) and activities normalized to a standard of caspase-3.
Computational Modeling
Computational modeling of NADH, NADPH, DJm, and Nnt activity was per-
formed with the integrated model of mitochondrial energetics, redox, and
ROS metabolic networks (Kembro et al., 2013). The model parameters wereCell Meas in Kembro et al. (2013), except for cytoplasmic ADP that was driven by
an exogenous function. The baseline level of cytoplasmic ADP was 5 mM,
with pulses of 20, 30, and 40 mM added for 200 s as shown by the ADPm tran-
sients in Figure 4A. To simulate the absence of Nnt activity, its forward and
reverse rate constants were reduced 10,000-fold.
Statistical Analyses
Values are displayed as mean ± SEM. One-way ANOVA followed by Tukey’s
multiple comparisons test, paired, and unpaired t tests, Fisher’s exact test,
and Kaplan-Meier survival analyses were performed using GraphPad Prism
version 6.00 for Windows (GraphPad, http://www.graphpad.com).
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